Insmed Inc (INSM)

Apr 17, 2025

Insmed CEO William Lewis sells $479,176 in stock By Investing.com - Investing.com Canada

Apr 17, 2025

Apr 16, 2025

Insmed CEO William Lewis sells $479,176 in stock - Investing.com

Apr 16, 2025

Apr 16, 2025

New cathepsin C inhibitors disclosed in Insmed patent - BioWorld MedTech

Apr 16, 2025

Apr 15, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - MarketScreener

Apr 15, 2025

Apr 15, 2025

Here's How Much You Would Have Made Owning Insmed Stock In The Last 5 Years - Benzinga

Apr 15, 2025

Apr 11, 2025

Commit To Purchase Insmed At $50, Earn 13.9% Annualized Using Options - Nasdaq

Apr 11, 2025

Apr 11, 2025

Cantor Fitzgerald maintains Overweight on Insmed stock, bullish on TPIP By Investing.com - Investing.com Canada

Apr 11, 2025

Apr 08, 2025

Is Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires? - Insider Monkey

Apr 08, 2025

Apr 04, 2025

Form DEF 14A INSMED Inc For: May 15 - StreetInsider

Apr 04, 2025

Apr 03, 2025

Insmed CEO William Lewis sells $502,577 in stock - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Insmed CEO William Lewis sells $502,577 in stock By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 02, 2025

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 - Insider Monkey

Apr 02, 2025

Mar 25, 2025

Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025

Mar 25, 2025

$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

Mar 25, 2025

Mar 25, 2025

Breakthrough Data: Insmed's Phase 3 Trial Could Transform Bronchiectasis Treatment - Stock Titan

Mar 25, 2025

Mar 25, 2025

Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference - Yahoo Finance

Mar 25, 2025

Mar 24, 2025

Wells Fargo Sticks to Their Buy Rating for Insmed (INSM) - The Globe and Mail

Mar 24, 2025

Mar 22, 2025

Insmed’s SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada

Mar 22, 2025

Mar 22, 2025

Insmed’s SWOT analysis: rare disease biotech stock poised for growth - Investing.com

Mar 22, 2025

Mar 20, 2025

Insmed reports preclinical data on INS-1201 for DMD - BioWorld MedTech

Mar 20, 2025

Mar 19, 2025

Insmed CEO William Lewis sells $1.97 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Insmed’s stock should triple after positive drug trial data, analyst says - MSN

Mar 19, 2025

Mar 19, 2025

H.C. Wainwright maintains Buy on Insmed stock, $90 target By Investing.com - Investing.com Canada

Mar 19, 2025

Mar 19, 2025

Insmed CEO William Lewis sells $1.97 million in stock - Investing.com India

Mar 19, 2025

Mar 19, 2025

Expert Outlook: Insmed Through The Eyes Of 13 Analysts - Benzinga

Mar 19, 2025

Mar 19, 2025

RBC maintains Outperform on Insmed stock, price target at $100 By Investing.com - Investing.com Canada

Mar 19, 2025

Mar 18, 2025

Insmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Mar 18, 2025

Mar 15, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 15, 2025

Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

US Bancorp DE Boosts Holdings in Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 12, 2025

Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 11, 2025

Insider Sell: Roger Adsett Sells 42,975 Shares of Insmed Inc (IN - GuruFocus.com

Mar 11, 2025

Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch - Investing.com

Mar 11, 2025

Mar 11, 2025

Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Smartleaf Asset Management LLC - Defense World

Mar 11, 2025

Mar 10, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) -March 10, 2025 at 08:01 am EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Insmed Expands Team with Stock Options Grant to 18 New Hires - StockTitan

Mar 10, 2025

Mar 08, 2025

UBS Group Raises Insmed (NASDAQ:INSM) Price Target to $110.00 - Defense World

Mar 08, 2025

Mar 07, 2025

Insmed’s Strategic Growth and Promising Pipeline Drive Buy Rating - TipRanks

Mar 07, 2025

Mar 06, 2025

UBS raises Insmed stock price target to $110 By Investing.com - Investing.com UK

Mar 06, 2025

Mar 06, 2025

Insmed CEO Lewis sells $1.99 million in stock By Investing.com - Investing.com Australia

Mar 06, 2025

Mar 05, 2025

Insmed CEO Lewis sells $1.99 million in stock - Investing.com India

Mar 05, 2025

Mar 05, 2025

Amalgamated Bank Boosts Stake in Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 05, 2025

Mar 05, 2025

Sanctuary Advisors LLC Acquires 464 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 05, 2025

Mar 01, 2025

Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024 - Star Tribune

Mar 01, 2025

Mar 01, 2025

RBC Capital starts Insmed at Outperform on brensocatib launch momentum - MSN

Mar 01, 2025